|
|
Article: CIMA LABS Announces License And Supply Agreement With Wyeth Consumer Healthcare.
- Article from:
- Business Wire
- Article date:
- June 27, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
CIMA LABS INC. (Nasdaq:CIMA) announced today it has signed a license and supply agreement with Wyeth Consumer Healthcare for a DuraSolv(R) loratadine over-the-counter version of Claritin(R) RediTabs(R). Under this agreement, CIMA will work with Wyeth Consumer Healthcare to complete the development and registration process, and will provide commercial supplies of DuraSolv loratadine. Wyeth Consumer Healthcare is a division of Wyeth (NYSE:WYE).
John M. Siebert, Ph.D., CIMA's President and Chief Executive Officer, commented: "This relationship developed as a result of the positive interaction CIMA had with Wyeth's ...